Section

Medicine

Clinical care, research, FDA

Vox

GLP-1 Drugs and the Stigma Surrounding Their Use

GLP-1 drugs are designed to treat obesity, but users often face stigma and judgment from society. Research shows that individuals who lose weight with these medications are perceived more negatively than those who lose weight through traditional methods. As GLP-1 usage increases, experts suggest that societal attitudes may evolve, potentially reducing the stigma surrounding their use.

Bias: 16 Sentiment: -0.20
Fox News — Latest

Jillian Michaels warns against dangers of unregulated weight loss drugs

Jillian Michaels has warned against the dangers of self-dosing unregulated weight-loss peptides, citing severe health risks associated with these products. The FDA has issued warnings regarding illegal sales and misleading marketing of GLP-1 compounds, emphasizing the importance of medical supervision for weight-loss treatments. Michaels cautioned that the trend is driven by individuals seeking quick weight loss, often influenced by unrealistic body standards.

Bias: 33 Sentiment: -0.10
studyfinds.com

Study Finds Increased Dementia Risk for Spouses of Affected Individuals

A recent study published in JAMA Network Open reveals that spouses of individuals diagnosed with dementia face a significantly higher risk of developing the condition themselves, with an increase of about 70%. The research highlights the importance of considering the health of both partners in the context of dementia, suggesting that families may benefit from closer monitoring and support.

Bias: 30 Sentiment: +0.00
Ars Technica

The Role of AI in Prior Authorization Processes

Prior authorization is a necessary process for obtaining approval from health insurers for medical treatments, but it can lead to delays that affect patient care. A 2025 survey indicated that many physicians are concerned that the introduction of AI in this process may worsen denial rates for necessary treatments, despite its potential to expedite approvals for clear cases.

Bias: 4 Sentiment: +0.00
The Daily Beast

54-Year-Old Woman Hospitalized After GLP-1 Medication Overdose

Leslie Gammon, a 54-year-old woman from North Carolina, was hospitalized due to an overdose of a GLP-1 medication prescribed through a telehealth service. After experiencing severe side effects, she spent three days in the hospital and has since stopped using the medication. Gammon is now seeking clarification from the telehealth company regarding her hospital expenses.

Bias: 4 Sentiment: -0.20